艾滋病毒状况和抗逆转录病毒治疗时代的艾滋病毒监测参与情况:南非农村基于人群和临床数据的关联研究。
HIV status and participation in HIV surveillance in the era of antiretroviral treatment: a study of linked population-based and clinical data in rural South Africa.
机构信息
Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Mtubatuba, South Africa.
出版信息
Trop Med Int Health. 2012 Aug;17(8):e103-10. doi: 10.1111/j.1365-3156.2012.02928.x.
OBJECTIVE
To examine whether HIV status affects participation in a population-based longitudinal HIV surveillance in the context of an expanding HIV treatment and care programme in rural South Africa.
METHOD
We regressed consent to participate in the HIV surveillance during the most recent fieldworker visit on HIV status (based on previous surveillance participation or enrollment in pre-antiretroviral treatment (pre-ART) care or ART in the local HIV treatment and care programme), controlling for sex, age and year of the visit (N = 25,940). We then repeated the regression using the same sample but, in one model, stratifying HIV-infected persons into three groups (neither enrolled in pre-ART care nor receiving ART; enrolled in pre-ART care but not receiving ART; receiving ART) and, in another model, additionally stratifying the group enrolled in pre-ART and the group receiving ART into those with CD4 count ≤ 200/μl (i.e. the ART eligibility threshold at the time) vs. those with CD4 count >200/μl.
RESULTS
HIV-infected individuals were significantly less likely to consent to participate in the surveillance than HIV-uninfected individuals [adjusted odds ratio (aOR), 0.74; 95% confidence interval, 0.70-0.79, P < 0.001], controlling for other factors. Persons who were receiving ART were less likely to consent to participate (aOR, 0.75, 0.68-0.84, P < 0.001) than those who had never sought HIV treatment or care (aOR, 0.82, 0.75-0.89, P < 0.001), but more likely to consent than persons enrolled in pre-ART care (aOR 0.62, 0.56-0.69, P < 0.001). Those with CD4 count ≤ 200/μl were significantly less likely to consent to participate than those with CD4 count >200/μl in both the group enrolled in pre-ART and the group receiving ART.
CONCLUSION
As HIV test results are not made available to participants in the HIV surveillance, our findings agree with the hypothesis that HIV-infected persons are less likely than HIV-uninfected persons to participate in HIV surveillance because they fear the negative consequences of others learning about their HIV infection. Our results further suggest that the increased knowledge of HIV status that accompanies improved ART access can reduce surveillance participation of HIV-infected persons, but that this effect decreases after ART initiation, in particular in successfully treated patients.
目的
在南非农村地区扩大艾滋病毒治疗和护理方案的背景下,研究艾滋病毒状况是否会影响参与基于人群的纵向艾滋病毒监测。
方法
我们根据之前的监测参与情况或在当地艾滋病毒治疗和护理方案中接受抗逆转录病毒前治疗(pre-ART)或抗逆转录病毒治疗(ART),将最近一次外勤人员访问时同意参与艾滋病毒监测的情况回归到艾滋病毒状况(N=25940)。然后,我们使用相同的样本重复了回归,但在一个模型中,将感染艾滋病毒的人分为三组(既未参加 pre-ART 护理,也未接受 ART;参加 pre-ART 护理,但未接受 ART;接受 ART),在另一个模型中,我们将参加 pre-ART 护理的人和接受 ART 的人进一步分为 CD4 计数≤200/μl(即当时接受 ART 的资格阈值)和 CD4 计数>200/μl。
结果
与未感染艾滋病毒的个体相比,感染艾滋病毒的个体参与监测的可能性显著降低[调整后的优势比(aOR),0.74;95%置信区间,0.70-0.79,P<0.001],控制了其他因素。正在接受 ART 的人同意参与的可能性低于从未寻求过艾滋病毒治疗或护理的人[aOR,0.75,0.68-0.84,P<0.001],但高于参加 pre-ART 护理的人[aOR,0.62,0.56-0.69,P<0.001]。在接受 pre-ART 护理的人和接受 ART 的人中,CD4 计数≤200/μl 的人同意参与的可能性显著低于 CD4 计数>200/μl 的人。
结论
由于艾滋病毒监测不向参与者提供艾滋病毒检测结果,因此我们的发现与以下假设一致,即与未感染艾滋病毒的个体相比,感染艾滋病毒的个体不太可能参与艾滋病毒监测,因为他们担心他人了解其艾滋病毒感染的负面后果。我们的研究结果进一步表明,随着获得抗逆转录病毒治疗的机会增加,艾滋病毒感染者对艾滋病毒状况的了解增加,可能会降低其参与艾滋病毒监测的可能性,但在开始接受抗逆转录病毒治疗后,特别是在成功治疗的患者中,这种影响会降低。
相似文献
引用本文的文献
Aust N Z J Public Health. 2022-12
BMC Pregnancy Childbirth. 2017-7-26
J Acquir Immune Defic Syndr. 2016-9-1
J Int AIDS Soc. 2015-11-26
本文引用的文献
Popul Health Metr. 2011-8-5
Trop Med Int Health. 2011-5-26
BMC Public Health. 2010-9-29
J Int AIDS Soc. 2010-1-12
Int J Epidemiol. 2011-4
Bull World Health Organ. 2009-10
AIDS Res Hum Retroviruses. 2009-4